[HTML][HTML] Molecular testing for thyroid nodules: the experience at McGill University teaching hospitals in Canada

M Rajab, RJ Payne, VI Forest, M Pusztaszeri - Cancers, 2022 - mdpi.com
Simple Summary The aim of this review is to provide a general overview about the
molecular markers (mutations and alterations) of thyroid cancers, present several molecular …

[HTML][HTML] Molecular features of aggressive thyroid cancer

G Elia, A Patrizio, F Ragusa, SR Paparo… - Frontiers in …, 2022 - frontiersin.org
Poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC) have a
worse prognosis with respect to well differentiated TC, and the loss of the capability of up …

Molecular profiling of 50 734 Bethesda III-VI thyroid nodules by ThyroSeq v3: implications for personalized management

S Chiosea, SP Hodak, L Yip, D Abraham… - The Journal of …, 2023 - academic.oup.com
Context Comprehensive genomic analysis of thyroid nodules for multiple classes of
molecular alterations detected in a large series of fine needle aspiration (FNA) samples has …

Thyroglobulin antibody (TgAb) positive is an independent risk factor for Lymph Node Metastasis in patients with differentiated thyroid carcinoma

Y Lai, Y Gu, M Yu, J Deng - International Journal of General …, 2023 - Taylor & Francis
Objective To investigate the relationship between lymph node metastasis and the
clinicopathologic features of differentiated thyroid carcinoma (DTC) patients with …

[HTML][HTML] Identification of R-Spondin Gene Signature Predictive of Metastatic Progression in BRAFV600E-Positive Papillary Thyroid Cancer

SD da Silva, GB Morand, L Diesel, JM de Lima, K Bijian… - Cells, 2022 - mdpi.com
Papillary thyroid carcinoma (PTC) is the most common malignancy of the thyroid gland and
early stages are curable. However, a subset of PTCs shows an unusually aggressive …

Investigation of genetic sex‐specific molecular profile in well‐differentiated thyroid cancer: Is there a difference between females and males?

GB Morand, I Tessler, J Krasner… - Clinical …, 2023 - Wiley Online Library
Background Although more common in females, thyroid cancer is deemed to be more
aggressive in males. The reasons for sex disparities in thyroid cancer are not well …

Molecular profiling for Bethesda III to VI nodules: results of a multicenter international retrospective study

GB Morand, I Tessler, M Noik, J Krasner, T Yamin… - Endocrine Practice, 2024 - Elsevier
Objective Molecular testing is a well-established tool that assists in the management of
thyroid nodules. We describe our experience using molecular testing of thyroid nodules with …

[HTML][HTML] The size of a thyroid nodule with ACR TI-RADS does not provide a better prediction of the nature of the nodule: a single-center retrospective real-life …

C Scorziello, C Durante, M Biffoni, MC Borcea… - Healthcare, 2023 - mdpi.com
We investigated if thyroid nodule size has a predictive value of malignancy on a par with
composition, echogenicity, shape, margin, and echogenic foci, and what would be the …

The Association of Pretreatment Systemic Immune Inflammatory Response Index (SII) and Neutrophil-to-Lymphocyte Ratio (NLR) with Lymph Node Metastasis in …

Y Gu, M Yu, J Deng, Y Lai - International Journal of General …, 2024 - Taylor & Francis
Objective Immunoinflammatory response can participate in the development of cancer. To
investigate the relationship between pretreatment systemic immune inflammatory response …

[HTML][HTML] Surgical outcomes of thyroid nodules positive for gene expression alterations using ThyroSeq V3 genomic classifier

S Salameh, M Rajab, VI Forest, M Pusztaszeri… - Cancers, 2022 - mdpi.com
Simple Summary This original research article aims to clarify the clinical and pathological
features of thyroid nodules that express a specific category of genetic alterations found on …